Literature DB >> 35681108

Metabolic Messengers: fibroblast growth factor 1.

Emanuel Gasser1, Gencer Sancar1, Michael Downes1, Ronald M Evans2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35681108     DOI： 10.1038/s42255-022-00580-2

Source DB:  PubMed          Journal:  Nat Metab        ISSN： 2522-5812


× No keyword cloud information.
  111 in total

Review 1.  The heparin-binding (fibroblast) growth factor family of proteins.

Authors:  W H Burgess; T Maciag
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

2.  Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice.

Authors:  D L Miller; S Ortega; O Bashayan; R Basch; C Basilico
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  FGF1 and insulin control lipolysis by convergent pathways.

Authors:  Gencer Sancar; Sihao Liu; Emanuel Gasser; Jacqueline G Alvarez; Christopher Moutos; Kyeongkyu Kim; Tim van Zutphen; Yuhao Wang; Timothy F Huddy; Brittany Ross; Yang Dai; David Zepeda; Brett Collins; Emma Tilley; Matthew J Kolar; Ruth T Yu; Annette R Atkins; Theo H van Dijk; Alan Saghatelian; Johan W Jonker; Michael Downes; Ronald M Evans
Journal:  Cell Metab       Date:  2022-01-04       Impact factor: 27.287

4.  Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain.

Authors:  T Maciag; T Mehlman; R Friesel; A B Schreiber
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

5.  An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization.

Authors:  T Maciag; J Cerundolo; S Ilsley; P R Kelley; R Forand
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Human endothelial cells: use of heparin in cloning and long-term serial cultivation.

Authors:  S C Thornton; S N Mueller; E M Levine
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

Review 7.  FGF1 - a new weapon to control type 2 diabetes mellitus.

Authors:  Emanuel Gasser; Christopher P Moutos; Michael Downes; Ronald M Evans
Journal:  Nat Rev Endocrinol       Date:  2017-06-30       Impact factor: 43.330

8.  Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer.

Authors:  Jae Myoung Suh; Johan W Jonker; Maryam Ahmadian; Regina Goetz; Denise Lackey; Olivia Osborn; Zhifeng Huang; Weilin Liu; Eiji Yoshihara; Theo H van Dijk; Rick Havinga; Weiwei Fan; Yun-Qiang Yin; Ruth T Yu; Christopher Liddle; Annette R Atkins; Jerrold M Olefsky; Moosa Mohammadi; Michael Downes; Ronald M Evans
Journal:  Nature       Date:  2014-07-16       Impact factor: 49.962

Review 9.  The Fibroblast Growth Factor signaling pathway.

Authors:  David M Ornitz; Nobuyuki Itoh
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-03-13       Impact factor: 5.814

10.  Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents.

Authors:  Jarrad M Scarlett; Jennifer M Rojas; Miles E Matsen; Karl J Kaiyala; Darko Stefanovski; Richard N Bergman; Hong T Nguyen; Mauricio D Dorfman; Louise Lantier; David H Wasserman; Zaman Mirzadeh; Terry G Unterman; Gregory J Morton; Michael W Schwartz
Journal:  Nat Med       Date:  2016-05-23       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.